检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:虞喜豪[1] 李新娉[1] 董桂云[1] 王建平[1] 虞文嫣[2] 熊茑[1]
机构地区:[1]解放军第 85 医院肿瘤病区,上海200052 [2]上海交通大学医学院基础医学部,上海200025
出 处:《肿瘤基础与临床》2014年第1期31-34,共4页journal of basic and clinical oncology
摘 要:目的探讨化疗联合γ-刀放疗在晚期复治肺癌治疗中的作用。方法83例晚期肺癌复治患者依据再次接受主要治疗方法,分为同步化放疗组(35例)、序贯化放疗组(26例)、单纯化疗组(22例)。放疗均采用γ-刀,总剂量35~50Gy。结果同步化放疗组、序贯化放疗组及单纯化疗组总有效率分别为17,1%、11.5%及31.8%,差异无统计学意义(P〉0.05)。Ⅲ期者以同步化放疗组略高(23.1%),Ⅳ期患者以单纯化疗组较高(38.5%)。总平均生存期及中位生存期以单纯化疗组最高,分别为14.2个月及9.3个月。各组先前曾行手术治疗的患者在后续复治中,生存期均长于非手术者。结论对于晚期复治肺癌患者,化疗联合γ-刀放疗同步治疗在Ⅲ期者中肿瘤缓解率略高,Ⅳ期者以单纯化疗有效率高,但各组相近。单纯化疗更有利于延长生存期。手术后复治患者生存优势明显。Objective To investigate the efficacy of chemotherapy plus γ-knife radiotherapy in the treatment ofpatients with advanced recurrent lung cancer. Methods Eighty-three patients with advanced recurrent lung cancer were divided into three groups according to the treatment: 35 patients were treated with synchronous chemoradiother- apy, 26 patients with seqential chemoradiotherapy and 22 patients with continuous chemotherapy alone. γ-knife was used in the radiotherapy. The total dose of 35-55 Gy was given. Results The overall response rates of the synchro- nous chemoradiotherapy group, the seqential chemoradiotherapy group and the continuous chemotherapy alone group were 17.1%, 11.5% and 31.8% , respectively (P 〉 0.05). The higher response rate was presented in theⅢ stage patients with synchronous chemoradiotherapy (23.1% ) , and in the Ⅳ stage with continuous systematized chemo- therapy alone (38.5%). The average overall survival time and median survival time of the patients treated by chem- otherapy alone were the highest ( 14.2 and 9.3 months). The total survival time of postoperative patients were lon- ger in the various groups than those of non-operations. Conclusion The synchronous chemoradiotherapy can partly increased the response rate of Ⅲ stage patients, and higher response rate was presented in Ⅳ stage with continuous systematized chemotherapy. Chemotherapy can prolong the survival time of the patients with lung cancer. There is survival superiority in postoperative patients.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.30